Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

2012/06/30 by Jay S. Cooper, Qiang Zhang, Thomas F. Pajak +17 · 5 citations
Medicine · #Head and Neck Cancer Studies #Head and Neck Surgical Oncology #Salivary Gland Tumors Diagnosis and Treatment

paper · doi:10.1016/j.ijrobp.2012.05.008

openalex publication_date 2012/06/30 · crossref created 2012/06/30 · crossref issued 2012/12/01 · crossref published 2012/12/01 · crossref published-print 2012/12/01 · crossref deposited 2024/04/26 · openalex created_date 2025/10/10 · crossref indexed 2026/07/31 · openalex updated_date 2026/08/01

Citations

• Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
• Nonparametric Estimation from Incomplete Observations

Cited by

• Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer
• Considerations in surgical versus non-surgical management of HPV positive oropharyngeal cancer
• Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer
• Treatment Deintensification for Human Papillomavirus-Associated Oropharyngeal Cancer
• HPV-positive oropharyngeal cancer [wikipedia]